UF neurologist co-recipient of Tom Isaacs Scientific Award
Drs. Michael Okun and Ray Dorsey were joint recipients of award recognizing researchers who have significantly impacted the lives of people living with Parkinson’s.
Posted in
Chronic Neurological Diseases News
FDA approves new ALS drug tested in clinical trial at UF
AMX0035 was tested at UF, Mass General and partnering sites and then approved by the FDA to treat ALS.
Parkinson disease treatment advances
Drs. Irene Malaty and Bhavana Patel co-author review in Practical Neurology about new agents, formulations and procedures to improve Parkinson’s treatment.
This geneticist’s goal: Cure the disease that runs in his family
UF Explore Magazine highlight’s Dr. Eric Wang’s innovative work at the UF Center for NeuroGenetics
Engineering the hi-fi brain
Dr. Kevin Otto co-leads public-private UF collaboration seeking to optimize clinical outcomes through novel neuroprostheses fabrication.
Tourette syndrome and tic disorders clinic renewed as Center of Excellence
Norman Fixel Institute received renewal as a Tourette Association of America Center of Excellence for an additional three years.
Study examines cause of “freezing” gait in Parkinson’s
Dr. Michael Okun provides insight into a study by researchers in Switzerland looking into the causes of “freezing” in Parkinson’s.
Identifying optimal timing of physical therapy to mitigate Parkinson’s symptoms
Drs. Ramzi Salloum and Michael Okun co-authored new JAMA Neurology viewpoint article.
DBS trial for difficult-to-treat Tourette syndrome shows promise
Human trial of closed-loop DBS in four participants with difficult-to-treat Tourette syndrome finds treatment to be safe, beneficial.
UF neurologists lead Parkinson’s program reaching local Black and African American community
Backed by a Parkinson’s Foundation grant, UF neurologists launched initiative to empower local Black and African American community through Parkinson’s education.
